Research programme: antifolates - Center for Infectious Disease Research/ GlaxoSmithKlineAlternative Names: antituberculars- Center for Infectious Disease Research/ GlaxoSmithKline
Latest Information Update: 24 Oct 2015
At a glance
- Originator Center for Infectious Disease Research; GlaxoSmithKline
- Class Antibacterials; Antituberculars
- Mechanism of Action Cell death modulators; Folate receptor 1 modulators; Folic acid transporter modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Mycobacterial infections